MedPath

Tivantinib

Generic Name
Tivantinib
Drug Type
Small Molecule
Chemical Formula
C23H19N3O2
CAS Number
905854-02-6
Unique Ingredient Identifier
PJ4H73IL17

Overview

Tivantinib has been investigated in Solid Tumors.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2015/11/18
Phase 2
Terminated
2014/05/30
Phase 1
Completed
2014/01/29
Phase 1
Completed
Armando Santoro, MD
2014/01/07
Phase 3
Completed
2013/07/04
Phase 2
Completed
Armando Santoro, MD
2013/05/23
Phase 2
Terminated
2012/12/24
Phase 3
Completed
2012/12/13
Phase 1
Completed
2012/11/12
Phase 1
Completed
2012/10/03
Phase 1
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath